Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) traded down 4.7% during trading on Wednesday . The stock traded as low as $26.22 and last traded at $25.96. 892,573 shares traded hands during mid-day trading, a decline of 62% from the average session volume of 2,378,834 shares. The stock had previously closed at $27.23.
Wall Street Analysts Forecast Growth
Several equities analysts have weighed in on the company. Raymond James Financial raised their price target on Acadia Healthcare from $26.00 to $30.00 and gave the company an "outperform" rating in a report on Friday, October 3rd. Royal Bank Of Canada cut their price target on Acadia Healthcare from $43.00 to $28.00 and set an "outperform" rating for the company in a report on Wednesday, August 13th. UBS Group cut their price target on Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating for the company in a report on Thursday, August 7th. Cowen restated a "buy" rating on shares of Acadia Healthcare in a report on Thursday, August 7th. Finally, Guggenheim cut their price target on Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating for the company in a report on Thursday, August 7th. Eight equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Acadia Healthcare has an average rating of "Moderate Buy" and a consensus target price of $35.09.
View Our Latest Report on ACHC
Acadia Healthcare Price Performance
The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73. The stock has a 50 day moving average of $22.43 and a 200-day moving average of $23.46. The stock has a market capitalization of $2.38 billion, a P/E ratio of 17.08, a price-to-earnings-growth ratio of 5.24 and a beta of 0.90.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share for the quarter, beating analysts' consensus estimates of $0.71 by $0.12. The business had revenue of $869.23 million during the quarter, compared to analyst estimates of $839.59 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.Acadia Healthcare's revenue was up 9.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. On average, equities research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.
Institutional Trading of Acadia Healthcare
Several large investors have recently added to or reduced their stakes in ACHC. Verdence Capital Advisors LLC lifted its holdings in shares of Acadia Healthcare by 3.3% in the 2nd quarter. Verdence Capital Advisors LLC now owns 14,656 shares of the company's stock valued at $333,000 after buying an additional 465 shares during the period. EverSource Wealth Advisors LLC lifted its holdings in shares of Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company's stock valued at $32,000 after buying an additional 497 shares during the period. PNC Financial Services Group Inc. lifted its holdings in shares of Acadia Healthcare by 10.3% in the 1st quarter. PNC Financial Services Group Inc. now owns 6,672 shares of the company's stock valued at $202,000 after buying an additional 622 shares during the period. LPL Financial LLC lifted its holdings in shares of Acadia Healthcare by 1.2% in the 1st quarter. LPL Financial LLC now owns 56,527 shares of the company's stock valued at $1,651,000 after buying an additional 697 shares during the period. Finally, UMB Bank n.a. lifted its holdings in shares of Acadia Healthcare by 149.5% in the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock valued at $38,000 after buying an additional 755 shares during the period.
About Acadia Healthcare
(
Get Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.